Hyperketonemia in Cattle

Hyperketonemia IS An elevated concentration of ketone bodies (acetone, acetoacetate, and beta-hydroxybutyrate [BHB]) in the blood.
Ketosis: The clinical expression of severe hyperketonemia, characterized by visible signs.
Subclinical Hyperketonemia: Elevated ketone levels occurring without clinical signs; both clinical and subclinical forms are part of the same disease syndrome.
Gateway Disease: Prevention is critical because hyperketonemia increases the risk of other early lactation issues like metritis and displaced abomasum.

Etiology & Pathogenesis:

The Metabolic Trigger: Requires a combination of intense adipose (fat) mobilization and high glucose demand, typically during early lactation.
The Liver Process: Fat mobilization increases serum nonesterified fatty acids (NEFAs); during intense gluconeogenesis, the liver directs these NEFAs toward ketone body synthesis.
Timing Variants:
- Immediate Postpartum (Week 1): Often associated with fatty liver and intense fat mobilization.
- Peak Milk Production (Weeks 2–6): Usually due to a metabolic shortage of gluconeogenic precursors in underfed, high-producing cows.
Secondary Cause: Ingestion of silage with high concentrations of butyric acid from clostridial fermentation.

Clinical Findings:

General Signs:
- Hyporexia/Anorexia: Cows often refuse grain before forage.
- Production Loss: Noticeable decrease in milk production and loss of body condition.
- Physical Markers: Firm, dry feces, lethargy, and an "empty-appearing" abdomen.
Nervous Ketosis (Neurological Signs):
- Occurs in a minority of cases but includes pica (chewing on pipes/objects) and abnormal licking/chewing.
- Incoordination, gait abnormalities, aggression, and bellowing.

Diagnosis & Monitoring:

Gold Standard: Enzymatic laboratory tests based on spectrophotometry.
Cowside Testing (Preferred):
- Blood (Most Accurate): Handheld BHB meters; threshold for hyperketonemia is ≥ 1.2 mmol/L.
- Milk: BHB dipsticks; threshold is 100 mcmol/L.
- Urine: Acetoacetate/acetone dipsticks; threshold is 15 mg/dL (interpreted within 5–10 seconds).
Monitoring Programs: Cost-effective for herds to test cows between 3 and 9 days in milk to evaluate prevalence and prevention strategies.

Treatment Protocols:

Primary Treatment: Oral drenching of propylene glycol (250–400 g once daily for 3–5 days) is considered the most efficacious.
Adjunct Therapy: Vitamin B12 (1.25–5 mg IM) to promote gluconeogenesis, particularly in hypoglycemic cows.
Nervous Ketosis: IV bolus of glucose (500 mL of 50% dextrose) to provide immediate, though transient, relief.
Refractory Cases: May require continuous IV glucose, tube feeding, or a temporary shift to once-daily milking to lower ketone concentrations.
Contraindication: The administration of glucocorticoids is explicitly not recommended.

Prevention & Control:

Body Condition Score (BCS): Manage BCS in late lactation to prevent cows from becoming too fat (BCS ≥ 3.75 on a 5-point scale) at calving.
Dry Period Management: Avoid decreasing BCS during the dry period as it may trigger prepartum fat mobilization.
Feed Intake: Promote consumption by minimizing stressors like overcrowding, heat stress, isolation, or empty feed bunks.
Nutritional Buffering: Early lactation diets should have enough fiber (28%–30% NDF) to maintain rumen health and high nonfiber carbohydrates (38%–41%) for energy.
Additives: Niacin, yeast, and rumen-protected choline may be helpful; monensin sodium is approved in some countries for prevention.

Hyperketonemia in Cattle

Hyperketonemia IS An elevated concentration of ketone bodies (acetone, acetoacetate, and beta-hydroxybutyrate [BHB]) in the blood.

Ketosis: The clinical expression of severe hyperketonemia, characterized by visible signs.

Subclinical Hyperketonemia: Elevated ketone levels occurring without clinical signs; both clinical and subclinical forms are part of the same disease syndrome.

Gateway Disease: Prevention is critical because hyperketonemia increases the risk of other early lactation issues like metritis and displaced abomasum.

Etiology & Pathogenesis:

The Metabolic Trigger: Requires a combination of intense adipose (fat) mobilization and high glucose demand, typically during early lactation.

The Liver Process: Fat mobilization increases serum nonesterified fatty acids (NEFAs); during intense gluconeogenesis, the liver directs these NEFAs toward ketone body synthesis.

Timing Variants:

Immediate Postpartum (Week 1): Often associated with fatty liver and intense fat mobilization.

Peak Milk Production (Weeks 2–6): Usually due to a metabolic shortage of gluconeogenic precursors in underfed, high-producing cows.

Secondary Cause: Ingestion of silage with high concentrations of butyric acid from clostridial fermentation.

Clinical Findings:

General Signs:

Hyporexia/Anorexia: Cows often refuse grain before forage.

Production Loss: Noticeable decrease in milk production and loss of body condition.

Physical Markers: Firm, dry feces, lethargy, and an "empty-appearing" abdomen.

Nervous Ketosis (Neurological Signs):

Occurs in a minority of cases but includes pica (chewing on pipes/objects) and abnormal licking/chewing.

Incoordination, gait abnormalities, aggression, and bellowing.

Diagnosis & Monitoring:

Gold Standard: Enzymatic laboratory tests based on spectrophotometry.

Cowside Testing (Preferred):

Blood (Most Accurate): Handheld BHB meters; threshold for hyperketonemia is ≥ 1.2 mmol/L.

Milk: BHB dipsticks; threshold is 100 mcmol/L.

Urine: Acetoacetate/acetone dipsticks; threshold is 15 mg/dL (interpreted within 5–10 seconds).

Monitoring Programs: Cost-effective for herds to test cows between 3 and 9 days in milk to evaluate prevalence and prevention strategies.

Treatment Protocols:

Primary Treatment: Oral drenching of propylene glycol (250–400 g once daily for 3–5 days) is considered the most efficacious.

Adjunct Therapy: Vitamin B12 (1.25–5 mg IM) to promote gluconeogenesis, particularly in hypoglycemic cows.

Nervous Ketosis: IV bolus of glucose (500 mL of 50% dextrose) to provide immediate, though transient, relief.

Refractory Cases: May require continuous IV glucose, tube feeding, or a temporary shift to once-daily milking to lower ketone concentrations.

Contraindication: The administration of glucocorticoids is explicitly not recommended.

Prevention & Control:

Body Condition Score (BCS): Manage BCS in late lactation to prevent cows from becoming too fat (BCS ≥ 3.75 on a 5-point scale) at calving.

Dry Period Management: Avoid decreasing BCS during the dry period as it may trigger prepartum fat mobilization.

Feed Intake: Promote consumption by minimizing stressors like overcrowding, heat stress, isolation, or empty feed bunks.

Nutritional Buffering: Early lactation diets should have enough fiber (28%–30% NDF) to maintain rumen health and high nonfiber carbohydrates (38%–41%) for energy.

Additives: Niacin, yeast, and rumen-protected choline may be helpful; monensin sodium is approved in some countries for prevention.